Ron Bache

Ron Bache is currently the CEO of Bache, Inc., an Allergan Special Advisor, and an Operating Partner with the private equity firm Invus Opportunities.

Bache advises startups and large multinational corporations on winning with amazing teams and technologies through focus, alignment, clear strategy, relentless execution, and always finding a way to overcome obstacles.

Bache is the former President and CEO of AqueSys, a venture capital backed medical device company which developed the XEN Gel Stent (acquired by Allergan). Prior to AqueSys, Ron was a Global Vice President at Advanced Medical Optics (acquired by Abbott), and has over 23 years of experience in the pharmaceutical and medical device industry.